Naltrexone is a chemical initially synthesized in 1963 and patented thereafter by the pharmaceutical company Endo Laboratories in 1967. It is considered a substituted derivative of oxymorphone in that the tertiary amine methyl-constituent is replaced with an allyl group (specifically an N-cyclopropylmethyl group) – or a longer chain of carbon atoms. It was initially approved …
Naltrexone is a pure opioid receptor antagonist utilized principally for the treatment of alcohol and opioid dependence. As an opioid receptor antagonist, naltrexone competitively binds to mu-opioid receptor (MOR) and kappa-opioid receptor (KOR) sites with higher affinity than opioid agonists, thereby attenuating receptor activation. Should an individual administer an opioid agonist (e.g. morphine) while taking …
Fioricet is a medication approved by the FDA for the treatment of three specific types of headaches including: tension, muscle contraction, and post-dural puncture. It contains a unique blend of a barbiturate (butalbital 50 mg), a pain reliever (acetaminophen 300 mg), and a stimulant (caffeine 40 mg); hence the reason it is sometimes abbreviated as Butal-Acet-Caff. …
Impulse control disorder (ICD) is an overarching classificatory label given to psychiatric disorders characterized by inability to resist impulses (or urges) that yield deleterious implications. Examples of impulse control disorders include: compulsive gambling, incessant sexual encounters, and binge shopping. If unrecognized and/or unaddressed for an extended duration, an impulse control disorder may ruin a person’s: …
Nearly all individuals taking Adderall can attest to the fact that its psychostimulatory effect is most potent after an initial “first-time” dosage. Thereafter, its efficacy is generally maintained for weeks, or perhaps months after the initial dosage with favorable results. However, eventually Adderall users may notice that its therapeutic psychostimulation seems to have dwindled and/or …
GHB (gamma-hydroxybutyric-acid) is a drug that was initially synthesized in 1874 by Alexander Zaytsev, but its effects weren’t researched in humans until the 1960s. Upon administration to humans, it was discovered that GHB functions as a short-acting CNS depressant. GHB alters neurotransmission via binding to multiple receptor sites within the brain including: GHB receptors and GABA(B) …
DXM (Dextromethorphan) is an antitussive agent comprised solely of a methylated dextrorotatory analogue of levorphanol, a semisynthetic non-opioid morphine derivative. It is classified as a “morphinan” drug and is an active ingredient within many over-the-counter (OTC) formulations utilized to treat allergies, coughing, influenza, and more. Examples of several popular over-the-counter formulations with DXM as an …